- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- November 2023
- 182 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- September 2023
- 30 Pages
United States
From €825EUR$920USD£735GBP
- Report
- February 2023
- 317 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- August 2020
- 105 Pages
Europe
From €2017EUR$2,100USD£1,736GBP
€2881EUR$3,000USD£2,481GBP
- Report
- August 2020
- 97 Pages
North America
From €2017EUR$2,100USD£1,736GBP
€2881EUR$3,000USD£2,481GBP
- Report
- August 2020
- 153 Pages
Asia Pacific
From €2017EUR$2,100USD£1,736GBP
€2881EUR$3,000USD£2,481GBP
- Report
- June 2020
- 180 Pages
Global
From €3059EUR$3,185USD£2,634GBP
€4370EUR$4,550USD£3,762GBP
- Report
- April 2023
- 115 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Report
- January 2022
- 111 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Report
- March 2021
- 90 Pages
Global
From €4322EUR$4,500USD£3,721GBP
- Report
- November 2022
- 120 Pages
Global
From €2401EUR$2,500USD£2,067GBP
- Report
- March 2021
- 183 Pages
Global
From €3458EUR$3,600USD£2,977GBP
- Report
- March 2021
- 83 Pages
Asia Pacific
From €1441EUR$1,500USD£1,240GBP
- Report
- February 2022
- 39 Pages
Global
From €1921EUR$2,000USD£1,654GBP
- Drug Pipelines
- August 2020
- 116 Pages
Global
From €1921EUR$2,000USD£1,654GBP
- Report
- February 2024
- 24 Pages
China, Hong Kong
From €825EUR$920USD£735GBP
- Report
- November 2023
- 25 Pages
India
From €825EUR$920USD£735GBP
- Report
- October 2023
- 25 Pages
Taiwan
From €825EUR$920USD£735GBP
The Decongestant market is a subset of the Cough and Cold Drugs market, which includes medications used to treat symptoms of the common cold, such as nasal congestion, sinus pressure, and chest congestion. Decongestants are typically available in both over-the-counter (OTC) and prescription forms, and are often used in combination with other medications to treat cold and flu symptoms. Decongestants work by narrowing the blood vessels in the nasal passages, reducing inflammation and allowing for easier breathing.
Common OTC decongestants include pseudoephedrine, phenylephrine, and oxymetazoline. Prescription decongestants include ephedrine, phenylephrine, and phenylpropanolamine. Decongestants are also available in combination with other medications, such as antihistamines, expectorants, and cough suppressants.
Some companies in the Decongestant market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Novartis, Merck, and Sanofi. Show Less Read more